PolyPid Faces Nasdaq Delisting Over Equity Shortfall
Ticker: PYPD · Form: 6-K · Filed: Jan 17, 2025 · CIK: 1611842
| Field | Detail |
|---|---|
| Company | Polypid Ltd. (PYPD) |
| Form Type | 6-K |
| Filed Date | Jan 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.5 million, $2.2 million, $14.5 million, $7.5 million, $27.0 million |
| Sentiment | bearish |
Sentiment: bearish
Topics: listing-compliance, delisting-risk, equity
TL;DR
Nasdaq says PolyPid's equity is too low, risking delisting.
AI Summary
PolyPid Ltd. received a non-compliance notification from Nasdaq on November 25, 2024, for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting only $2.2 million as of September 30, 2024. The company is now subject to Nasdaq's delisting procedures.
Why It Matters
Failure to regain compliance could lead to PolyPid's delisting from the Nasdaq Capital Market, impacting its stock liquidity and investor confidence.
Risk Assessment
Risk Level: medium — The company is at risk of delisting from Nasdaq if it cannot regain compliance with the minimum stockholders' equity requirement.
Key Numbers
- $2.5M — Minimum Stockholders' Equity (Required by Nasdaq for continued listing on the Capital Market.)
- $2.2M — Reported Stockholders' Equity (PolyPid's equity as of September 30, 2024, below the Nasdaq requirement.)
Key Players & Entities
- PolyPid Ltd. (company) — The company filing the report and subject to Nasdaq rules.
- Nasdaq (company) — The stock exchange that issued the non-compliance notification.
- $2.5 million (dollar_amount) — The minimum stockholders' equity required for Nasdaq listing.
- $2.2 million (dollar_amount) — PolyPid's reported stockholders' equity as of September 30, 2024.
- November 25, 2024 (date) — The date Nasdaq notified PolyPid of non-compliance.
- September 30, 2024 (date) — The date as of which PolyPid's stockholders' equity was reported.
FAQ
What specific Nasdaq rule did PolyPid violate?
PolyPid violated Nasdaq Listing Rule 5550(b)(1), which requires companies to maintain a minimum of $2.5 million in stockholders' equity.
When was PolyPid notified of its non-compliance?
PolyPid was notified by the Nasdaq Listing Qualifications staff on November 25, 2024.
What was PolyPid's stockholders' equity as of the reporting date?
As of September 30, 2024, PolyPid reported stockholders' equity of $2.2 million.
What is the consequence of failing to meet the stockholders' equity requirement?
Failure to meet the requirement subjects the company to Nasdaq's delisting procedures.
What is the company's principal executive office address?
The company's principal executive office is located at 18 Hasivim Street, Petach Tikva 495376, Israel.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-17 16:05:07
Key Financial Figures
- $2.5 million — Capital Market to maintain a minimum of $2.5 million in stockholders’ equity for conti
- $2.2 million — reported stockholders’ equity of $2.2 million as of September 30, 2024 in its Report
- $14.5 million — (the “PIPE”), resulting in $14.5 million of gross proceeds from the sale of its
- $7.5 million — squo; equity increased to approximately $7.5 million. Pursuant to the PIPE, the investors al
- $27.0 million — s in full would result in an additional $27.0 million in gross proceeds. The warrants expire
Filing Documents
- ea0227903-6k_polypid.htm (6-K) — 12KB
- 0001213900-25-004603.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. POLYPID LTD. Date: January 17, 2025 By: /s/ Dikla Czaczkes Akselbrad Name: Dikla Czaczkes Akselbrad Title: Chief Executive Officer 2